TULSA, OK — Federal health inspectors identified five deficiencies at Montereau, Inc. during a complaint investigation concluded on November 21, 2025, including failures in pharmaceutical labeling and controlled substance storage that posed potential risks to residents.
Drug Labeling and Storage Failures
The investigation found that Montereau, Inc. did not ensure drugs and biologicals used within the facility were labeled according to currently accepted professional standards. Inspectors also documented that controlled substances were not stored in properly locked compartments, a violation of federal regulations requiring separate secured storage for these medications.
The deficiency was cited under regulatory tag F0761, which governs pharmacy services and requires that all drugs and biologicals be stored in locked compartments with controlled drugs kept in separately locked areas. The scope and severity was classified as Level E, indicating a pattern of non-compliance rather than an isolated incident — though no actual harm to residents was documented at the time of the investigation.
A Level E classification means the problem was observed across multiple instances or areas of the facility, raising concerns about systemic gaps in pharmaceutical management protocols.
Why Proper Drug Storage Matters
Controlled substance storage requirements exist for critical safety reasons. Medications that are not properly secured can be accessed by unauthorized individuals, increasing the risk of drug diversion, accidental ingestion, or dosing errors. In a nursing home setting where residents may have cognitive impairments such as dementia, unsecured medications present a particularly significant hazard.
Proper labeling is equally essential. When drugs are not labeled in accordance with professional standards, staff members may confuse medications, administer incorrect dosages, or give a drug to the wrong resident. Medication errors are among the leading causes of preventable harm in long-term care facilities, and clear labeling serves as a fundamental safeguard against such incidents.
Federal pharmacy service standards require that every medication in a nursing facility be clearly identified with the drug name, strength, expiration date, and any necessary storage instructions. Controlled substances — which include opioid pain medications, sedatives, and other drugs with potential for misuse — must be kept under double-lock conditions to maintain chain-of-custody accountability.
A Pattern, Not an Isolated Incident
The Level E designation is particularly noteworthy. When inspectors classify a deficiency at this level, it indicates the problem was not confined to a single occurrence but was instead observed as a recurring pattern within the facility. This suggests that the pharmaceutical storage and labeling issues reflected broader procedural breakdowns rather than a one-time oversight.
The drug storage citation was one of five total deficiencies identified during the complaint-driven inspection, indicating multiple areas of regulatory non-compliance were found during the visit. Complaint investigations are initiated when concerns are reported to state or federal agencies, unlike routine annual surveys that follow a standard schedule.
Facility Response and Correction
Montereau, Inc. was classified as deficient with a provider-reported date of correction of December 24, 2025, approximately one month after the inspection. This timeline suggests the facility took steps to address the pharmaceutical storage and labeling issues identified by inspectors.
Facilities that receive deficiency citations are required to submit a plan of correction detailing the specific actions taken to resolve each identified problem and prevent recurrence. Follow-up inspections may be conducted to verify that corrections have been properly implemented.
Industry Standards for Pharmaceutical Management
Accredited long-term care facilities are expected to maintain rigorous pharmaceutical management systems that include regular audits of medication storage areas, verification of labeling accuracy, and documentation of controlled substance counts at each shift change. These protocols are designed to create multiple layers of protection against medication-related incidents.
The Centers for Medicare & Medicaid Services (CMS) requires nursing facilities participating in federal programs to comply with pharmacy service regulations as a condition of participation. Repeated or severe pharmaceutical violations can result in enforcement actions including fines, increased monitoring, or changes to a facility's participation status.
Montereau, Inc. is a senior living community located in Tulsa, Oklahoma. The full inspection report, including all five deficiencies cited during the November 2025 investigation, is available for public review through the CMS Care Compare database.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Montereau, Inc. from 2025-11-21 including all violations, facility responses, and corrective action plans.
💬 Join the Discussion
Comments are moderated. Please keep discussions respectful and relevant to nursing home care quality.